InfuSystem Holdings INFU Device Solutions — Depreciation
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by InfuSystem Holdings in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSoldDepreciation.
The official record: InfuSystem Holdings’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about InfuSystem Holdings's device solutions — depreciation.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is InfuSystem Holdings's device solutions — depreciation?
- InfuSystem Holdings (INFU) reported device solutions — depreciation of $874K in Q1 2026.
- How has InfuSystem Holdings's device solutions — depreciation changed year-over-year?
- InfuSystem Holdings's device solutions — depreciation decreased by 7.3% year-over-year, from $943K to $874K.
- What is the long-term trend for InfuSystem Holdings's device solutions — depreciation?
- Over 2 years (2023 to 2025), InfuSystem Holdings's device solutions — depreciation has grown at a 11.5% compound annual growth rate (CAGR), from $3.05M to $3.79M.
- What does device solutions — depreciation mean?
- The non-cash expense allocated to the Device Solutions segment to account for the wear and tear of medical equipment and other fixed assets over their useful lives. This reflects the capital intensity of the segment's business model.